BONTAGRRO
"BONTAGRRO" is a figurative mark owned by Hong Kong King-Friend, Industrial Company, Ltd., filed at the UKIPO on June 4, 2026. It is registered and covers class 5 (Pharmaceuticals).
- Status
- Registered
- Since June 4, 2026
- Filed
- June 4, 2026
- Registered
- August 28, 2026
- Expires
- Not recorded
- Application no.
- UK00004397129
- Registration no.
- UK00004397129
- Office
- UKIPO
- Intellectual Property Office
- Mark type
- Figurative mark
- 1 class
Who owns BONTAGRRO
The owner and representative on file with the office.
Owner
Hong Kong King-Friend, Industrial Company, Ltd.
Hong Kong SAR China
Representative
Bryers Intellectual Property Ltd
Bryers Intellectual Property Ltd
What the mark covers
The products and services BONTAGRRO is filed for, grouped by Nice class.
Pharmaceuticals; pharmaceutical preparations; pharmaceutical products; biologics; biosimilars; filgrastim biosimilars; pharmaceutical preparations for the treatment of neutropenia; pharmaceutical preparations for the treatment of low white blood cells; pharmaceutical preparations for use in stimulating white blood cell production; biosimilars for use in stimulating white blood cell production; pharmaceutical preparations, namely, recombinant-human granulocyte-CSF for use in stimulating white blood cell production; recombinant-human granulocyte-CSF biosimilars for use in stimulating white blood cell production; pharmaceutical preparations, namely, injectable filgrastim biosimilars; pharmaceutical preparations, namely, injectable biosimilars for the treatment of neutropenia; pharmaceutical preparations, namely, injectable biosimilars for the treatment of low white blood cells; pharmaceutical preparations, namely, injectable biosimilars for use in stimulating white blood cell production; pharmaceutical preparations, namely, injectable recombinant-human granulocyte-CSF for use in stimulating white blood cell production; pharmaceutical preparations, namely, injectable recombinant-human granulocyte-CSF biosimilars for use in stimulating white blood cell production; injectors sold filled with filgrastim biosimilars; injectors sold filled with pharmaceutical preparations for the treatment of neutropenia; injectors sold filled with pharmaceutical preparations for the treatment of low white blood cells; injectors sold filled with pharmaceutical preparations for use in stimulating white blood cell production; injectors sold filled with biosimilars for use in stimulating white blood cell production; injectors sold filled with recombinant human granulocyte-CSF for use in stimulating white blood cell production; injectors sold filled with recombinant-human granulocyte-CSF biosimilars for use in stimulating white blood cell production.
About BONTAGRRO
Who owns the trademark "BONTAGRRO"?
The UKIPO trademark "BONTAGRRO" (application UK00004397129) is owned by Hong Kong King-Friend, Industrial Company, Ltd.
What is the status of "BONTAGRRO"?
Its status at the UKIPO is: registered.
When was "BONTAGRRO" registered?
It was registered on August 28, 2026.
Get this data via the API
Everything on this page comes from the Signa API. Pull BONTAGRRO and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019f427e-926a-7299-948e-2aee40d16644
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019f427e-926a-7299-948e-2aee40d16644",
"object": "trademark",
"mark_text": "BONTAGRRO",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "GB",
"application_number": "UK00004397129",
"filing_date": "2026-06-04",
"nice_classes": [
5
],
"owners": [
{
"name": "Hong Kong King-Friend, Industrial Company, Ltd.",
"entity_id": null
}
]
}